CLINICAL_TRIALS
trial_result
· 2011-08-29
Clinical Trial Update: Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of alogliptin in adults with Type 2 diabetes; results were posted after completion of the study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-08-29